Postoperative Outcomes and Risk Profiles in Dual Liver–Lung Transplantation: A Single‐Center Retrospective Analysis
Journal of Transplantation · 2026-01 · 2026 (1)
DOI: 10.1155/joot/9414873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Transplantation, online erschienen am 08.04.2026. Verfasst von Abdulmalik Saleem und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA, henryford.com. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dual liver–lung transplantation (DLLT) is an uncommon but definitive therapy for carefully selected patients with concurrent end‐stage hepatic and pulmonary disease. The combined operative complexity and dual‐organ immunosuppressive burden may predispose recipients to early morbidity and graft‐threatening complications [1–4].
Objective
To characterize early and late postoperative events (including acute cellular rejection (ACR), infectious complications, malignancy, and hospital readmissions) after DLLT and to describe associated clinical patterns.
Methods
We performed a retrospective cohort study of adult DLLT recipients at a single tertiary center (2013–2024). Variables included demographics, transplant indications, ischemia times, readmissions (0–3 months; 3–12 months), infections (timing/etiology/site), biopsy‐proven rejection, malignancy, and survival. ACR was biopsy‐confirmed in cases of unexplained transaminitis beyond 30 days posttransplant. Analyses were descriptive, consistent with STROBE recommendations for small cohorts.
Results
Ten patients (mean age 53.7 years; 50% female) underwent DLLT. Liver etiologies included alcohol‐related cirrhosis ( n = 2), HCV ( n = 1), cryptogenic ( n = 1), autoimmune ( n = 1), cystic fibrosis ( n = 1), and unspecified ( n = 4). Lung indications were IPF ( n = 5), pulmonary hypertension ( n = 2), ILD ( n = 2), and CF ( n = 1). All patients were readmitted within 90 days, most commonly for infection (40%), diarrhea (20%), critical illness myopathy (20%), rejection (10%), and biliary stricture (10%). Biopsy‐proven ACR occurred in 4/10 patients (40%) after the first month, uniformly presenting with hepatocellular transaminemia; 3/4 received pulse‐dose IV corticosteroids and 2/3 subsequently developed invasive fungal disease (Aspergillus and Candida ). Overall, 9/10 experienced infection within 6 months, predominantly pulmonary (fungal/bacterial pneumonias). Three patients developed malignancy (basal cell carcinoma, prostate carcinoma, and angiosarcoma [fatal]). Survival was 90% at 1 year, 70% at 3 years, and 60% at 5 years; no 10 year survivors were observed.
Conclusions
DLLT is associated with early readmission and a high infectious burden, particularly invasive fungal disease after steroid‐treated ACR. Despite significant early morbidity, short‐term survival is favorable. Multicenter studies are needed to refine candidate selection, balance rejection prophylaxis with antifungal strategies, and standardize long‐term oncologic and dermatologic surveillance in DLLT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA, henryford.com.
- Department of Internal Medicine, Michigan State University College of Human Medicine, East Lansing, Michigan, USA, msu.edu.
- Department of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan, USA, henryford.com.
- Department of Internal Medicine, Cornell University School of Medicine, Ithaca, New York, USA.
- Department of Transplant Surgery, Henry Ford Hospital, Detroit, Michigan, USA, henryford.com.
- Department of Pulmonary Transplant, Henry Ford Hospital, Detroit, Michigan, USA, henryford.com.
ORCID-Profile: Abdulmalik Saleem, Omar Ilyas, Muhammad Saad Faisal, Ammad Chaudhary, Uthman Shukairy, Domingo Franco-Palacios, Adarsh Varma, Syed-Mohammed Jafri
Zitieren
APA
Saleem, A., Ilyas, O., Obri, M., Alomari, A., Faisal, M. S., Omeish, H., Chaudhary, A., Dababneh, Y., Shukairy, U., Nagai, S., Franco-Palacios, D., Venkat, D., Varma, A., & Jafri, S. M. (2026). Postoperative Outcomes and Risk Profiles in Dual Liver–Lung Transplantation: A Single‐Center Retrospective Analysis. Journal of Transplantation, 2026(1). https://doi.org/10.1155/joot/9414873
Vancouver
Saleem A, Ilyas O, Obri M, Alomari A, Faisal MS, Omeish H, et al. Postoperative Outcomes and Risk Profiles in Dual Liver–Lung Transplantation: A Single‐Center Retrospective Analysis. Journal of Transplantation. 2026;2026(1). doi:10.1155/joot/9414873
BibTeX
@article{Saleem2026,
author = {Saleem, Abdulmalik and Ilyas, Omar and Obri, Mark and Alomari, Ahmad and Faisal, Muhammad Saad and Omeish, Haya and Chaudhary, Ammad and Dababneh, Yara and Shukairy, Uthman and Nagai, Shunji and Franco-Palacios, Domingo and Venkat, Deepak and Varma, Adarsh and Jafri, Syed-Mohammed},
title = {Postoperative Outcomes and Risk Profiles in Dual Liver–Lung Transplantation: A Single‐Center Retrospective Analysis},
journal = {Journal of Transplantation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joot/9414873}
}
EUVIMED